Last reviewed · How we verify
Adipose derived stromal cells intravenously injected
At a glance
| Generic name | Adipose derived stromal cells intravenously injected |
|---|---|
| Sponsor | Assistance Publique - Hôpitaux de Paris |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- LYell SYndrome MEsenchymal Stromal Cells Treatment (PHASE1, PHASE2)
- SVF (Adipose Tissue Derived MSC) Based Therapy for CKD. (PHASE1, PHASE2)
- Use of Stem Cells in Diabetes Mellitus Type 1 (PHASE1)
- Adipose Derived Stem Cell Therapy for Autism (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: